Xcout Intel
ImmunoPhotonics, Inc.
ImmunoPhotonics, Inc. is a privately owned clinical-stage biopharmaceutical and pharmaceutical manufacturing company located in St. Louis, Missouri, specializing in interventional immuno-oncology.
Subscribe to see ImmunoPhotonics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ImmunoPhotonics, Inc. at a glance
ImmunoPhotonics, Inc. is a biotechnology company headquartered in United States. It has raised at least $40.8M across the 7 funding rounds on record, 6 of them with a disclosed amount. Its most recent funding round raised $10.1M in July 2025. Xcout tracks 22 named people at ImmunoPhotonics, Inc., including Robert H. Arch (CEO & PRESIDENT).
ImmunoPhotonics, Inc. leadership
- Robert H. ArchCEO & PRESIDENT
- Alexander M. HurstCHIEF CORPORATE OFFICER & GENERAL COUNSEL
- Edwina Baskin-BeyCHIEF MEDICAL OFFICER
- Jonathan KnowlesCHAIRMAN
- Lu AlleruzzoCO-FOUNDER & DIRECTOR
- Wei R. ChenCO-FOUNDER, CO-INVENTOR & DIRECTOR
16 more named people on record for ImmunoPhotonics, Inc., with roles, board committees and tenure — see the full roster →
ImmunoPhotonics, Inc. funding rounds
At least $40.8M raised across the 7 rounds on record (6 with a disclosed amount). The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10.1M | — | |
| SEC Form D filing | $1.5M | — | |
| SEC Form D filing | $3.5M | — | |
| Series B | $21.4M | — | |
| Series A | $2.5M | — | |
| Series A | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
ImmunoPhotonics, Inc. competitors
A few of ImmunoPhotonics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Immunomic Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, that develops innovative immune therapies.
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Get ImmunoPhotonics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ImmunoPhotonics, Inc. in Xcout Intel
- 22 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access